GlaxoSmithKline's Long-Acting HIV Regimen Gets CRL From FDA

·

·

GlaxoSmithKline's Long-Acting HIV Regimen Gets CRL From FDA

GlaxoSmithKline plc’s GSK HIV subsidiary, ViiV Healthcare, and partner J&J JNJ received a complete response letter (CRL) from the FDA for its investigational long-acting injectable regimen of cabotegravir and J&J’s Edurant (rilpivirine) for the treatment of …
See Original Article

Fed's Diversity Push; Bets on Higher Inflation Rise; Reaction to New BOE Chief; Do Negative Rates Work?

Good day. The Federal Reserve in recent years has been seeking to include more women and minorities in its ranks, as the wider economics profession has long been dominated by white men. The focus on diversity has coincided with veteran female staffers …
See Original Article

No. 1 Stock Market in Americas Forecast to Climb 15% Next Year

… climb 15 percent from Friday's close to 131,900 by the end of next year, according to the average estimate of 10 strategists surveyed by Bloomberg.
See Original Article

AICPA seeks input on proposed CPA Exam changes

The profession is placing greater reliance on SOC reports as clients are outsourcing more accounting processes, impacting the work of newly licensed
See Original Article

Credit Suisse Again Lays Spy Blame on Former Chief Operating Officer

Credit Suisse Group AG Monday confirmed a second episode of bank-mandated spying on senior executives this year, deepening scrutiny of the Swiss bank’s surveillance practices and decision-making by top management. In a statement the bank blamed …
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.